Swiss Semiconductors Stock News

Alcon (SWX:ALC) opened 2026 with Q1 revenue of US$2.7b and basic EPS of US$0.39, setting a clear marker for how the year is starting after a period where trailing 12 month revenue sat at US$10.6b and EPS at US$1.67. Over recent quarters, the company has seen revenue move from US$2.5b in Q4 2024 to around US$2.7b in Q1 2026, while quarterly EPS has ranged from US$0.36 to US$0.71. This gives investors a wide set of earnings outcomes to weigh against a reported trailing net margin of 7.7% and...

Investors may be wondering if Novartis at CHF113.54 is still offering value, or if most of the easy gains are already on the table. The stock is up 25.9% over the last year and 41.9% over 3 years, even though it shows a 1% decline over 7 days, a 7.8% decline over 30 days, and a 4.6% return year to date. Recent headlines have focused on Novartis as a large global pharmaceutical business, with investors watching how its product portfolio and pipeline shape long term expectations. This context...

Temenos (SWX:TEMN) has secured new SaaS core banking agreements with First Abu Dhabi Bank in Saudi Arabia and Questrade in Canada. The company is expanding its SaaS offering on Amazon Web Services to cover end to end digital banking and payments. These updates relate to Temenos' cloud banking platform and its global client reach across the Middle East and North America. For Temenos, a provider of core banking and digital banking software, these wins highlight how large banks and non bank...

Swiss lawmakers are advancing reforms that could impose major new capital requirements on UBS Group's Swiss unit following the Credit Suisse acquisition. The proposed rules aim to reshape UBS's regulatory obligations and risk profile in Switzerland. This legislative process is ongoing and could have a direct impact on UBS's future capital structure and profitability. For investors watching SWX:UBSG, this comes at a time when the stock trades at around CHF34.56 and has delivered a 39.5%...

Bachem Holding (SWX:BANB) is back in focus after announcing the departure of Chief Commercial Officer Torsten Wöhr. CEO Anne-Kathrin Stoller is set to temporarily assume commercial responsibilities from May 25, 2026. See our latest analysis for Bachem Holding. The leadership change comes as Bachem Holding’s share price trades at CHF75.45, with a 7 day share price return of 10.71% and a year to date share price return of 29.08%. The 1 year total shareholder return of 54.39% contrasts with a 3...

Dividend decision and board changes put Accelleron Industries (SWX:ACLN) in focus Accelleron Industries (SWX:ACLN) drew investor attention after shareholders approved a higher CHF 1.50 per share dividend for the 2025 financial year at the 2026 Annual General Meeting. See our latest analysis for Accelleron Industries. Alongside the higher dividend and board refresh, Accelleron Industries’ CHF85.35 share price sits after a 34.62% year to date share price return and a very strong 3 year total...

In April 2026, SGS SA held its Q1 2026 sales and trading statement call, providing investors with an update on recent operating trends and management’s latest commentary on the business. This routine update appears to have meaningfully influenced investor sentiment, highlighting how even scheduled disclosures about trading conditions and outlook can reshape perceptions of SGS’s longer-term prospects. We’ll now consider how the Q1 2026 trading update, and any shifts in management commentary...

Landis+Gyr Group (SWX:LAND) has joined EPRI’s Open Power AI Consortium, a collaboration focused on open-source AI and GenAI tools for electric utilities tackling reliability, efficiency, and customer service challenges. See our latest analysis for Landis+Gyr Group. At a share price of CHF53.0, Landis+Gyr’s recent 1 day share price return of 1.15% and 30 day share price return of 3.92% sit against a softer 3 year total shareholder return of 28.59% decline. This suggests recent momentum has...

Temenos (SWX:TEMN) has just paired a first quarter earnings update with a change in its finance leadership, providing fresh information on both its recent financial performance and how the company is organizing for future execution. See our latest analysis for Temenos. At a share price of CHF75.0, the stock has recovered from a softer start to the year, with a 90 day share price return of 16.64% and a 1 year total shareholder return of 27.33%. This suggests that recent momentum has been...

What Idorsia’s new QUVIVIQ guidance tells you Idorsia (SWX:IDIA) has put QUVIVIQ at the center of its 2026 outlook, guiding for CHF 200 million in sales after releasing its first quarter results and updating progress on its broader pipeline and partnerships. See our latest analysis for Idorsia. Following the first quarter update and QUVIVIQ guidance, Idorsia’s recent share price moves look mixed, with a 30 day share price return of 8.16% but a year to date share price return of a 6.35%...

Roche Holding stock: recent move puts long term returns in context Roche Holding (SWX:ROP) has drawn attention after a recent pullback, with the stock down about 0.6% over the past day and just over 1% over the past week. For readers tracking longer horizons, the share price shows a small decline over the past month and a larger negative move over the past 3 months, while multi year total returns remain positive. See our latest analysis for Roche Holding. At a share price of CHF316.5, Roche...

OC Oerlikon (SWX:OERL) rose 4.13% on April 30, 2026, on heavier trading within the industrial machinery sector, as some investors appeared to reposition before the company’s August 6 earnings announcement. See our latest analysis for OC Oerlikon. That 4.43% 1 day share price return and 5.24% 7 day gain come after a weaker 90 day share price return of 8.45%, while the 1 year total shareholder return of 30.25% contrasts with losses over three and five years. This suggests short term momentum...

As the European market navigates a complex landscape marked by flat performance in the STOXX Europe 600 Index and cautious sentiment due to geopolitical tensions and rising oil prices, investors are increasingly on the lookout for opportunities within small-cap stocks that might offer untapped potential. In this environment, a good stock is often characterized by strong fundamentals, resilience in earnings growth despite broader economic challenges, and strategic positioning that can...

Schindler Holding (SWX:SCHN) has drawn fresh attention after reporting first quarter 2026 results, with sales of CHF 2,593 million, net income of CHF 262 million and basic EPS from continuing operations of CHF 2.34. See our latest analysis for Schindler Holding. The first quarter update, with lower sales but slightly higher net income and EPS, comes after a 4.59% 1 month share price return. The year to date share price return of 8.07% and 1 year total shareholder return of 5.53% indicate...

In late April 2026, Sandoz Group reported Q1 results showing 3% net sales growth at constant currency, led by 18% growth in biosimilars, while also confirming its full-year 2026 outlook for mid- to high-single-digit sales growth and core EBITDA margin expansion. The company also announced a new partnership with Samsung Bioepis covering up to five biosimilar assets, a move that materially broadens its pipeline and reinforces its push into higher-value biologic medicines. We’ll now examine how...

Kuehne + Nagel International (SWX:KNIN) shares are reacting to first quarter results, where sales reached CHF 5,603 million and net income CHF 245 million, both below the CHF 6,330 million and CHF 291 million reported a year earlier. See our latest analysis for Kuehne + Nagel International. The softer first quarter figures appear to sit alongside a mixed price picture, with a 5.0% year to date share price return but a 0.01% decline in total shareholder return over the past year. This...

Helvetia Baloise Holding (SWX:HBAN) has come to market with three senior fixed rate bond issues, raising a total of CHF 550 million across 2028, 2032 and 2036 maturities. This provides investors with fresh information on its funding approach. See our latest analysis for Helvetia Baloise Holding. These bond issues come after a period where the share price has generally been firm, with a 90 day share price return of 7.21%, while total shareholder returns of 16.49% over one year and 141.36% over...

It looks like Avolta AG ( VTX:AVOL ) is about to go ex-dividend in the next four days. The ex-dividend date is usually...

New SEN62 module puts Sensirion’s air quality focus in the spotlight Sensirion Holding (SWX:SENS) has released the SEN62 environmental sensing module to the broader market, giving device makers a compact way to measure particulate matter, humidity and temperature in air quality focused products. See our latest analysis for Sensirion Holding. The latest SEN62 launch lands as Sensirion’s share price sits at CHF67.4, with a 30 day share price return of 11.59% and a 90 day gain of 17.63%. This...

Huber+Suhner (SWX:HUBN) is back on investor radars after expanding its work with Microsoft on hollow core fiber, supplying cables and connectors that are already deployed within the Azure cloud network. See our latest analysis for Huber+Suhner. That Microsoft HCF agreement arrives as momentum in the shares has already been strong, with a 30 day share price return of 22.7% and a year to date gain of 48.04% alongside a 1 year total shareholder return above 200%, suggesting sentiment has shifted...

Roche Holding (SWX:ROP) reported positive Phase III data for fenebrutinib in relapsing multiple sclerosis, with meaningful reductions in relapse rates and disease burden. The company shared new real world and clinical data in ophthalmology for Vabysmo, Susvimo and investigational IL 6 inhibitor vamikibart, highlighting developments in retinal disease therapies. Roche and Zealand Pharma are moving obesity candidate petrelintide into Phase 3 trials, targeting chronic weight related conditions...

What triggered fresh interest in Siegfried Holding? Siegfried Holding (SWX:SFZN) has drawn attention after raising its 2026 earnings guidance to high single digit net sales growth, while subsidiary DINAMIQS secured Swissmedic approval for cGMP viral vector manufacturing and testing. See our latest analysis for Siegfried Holding. The raised 2026 guidance and DINAMIQS approval come after a mixed share price pattern, with a 1 day share price return of 1.48% and a 90 day share price return...

Why the latest sales update matters for Nestlé shares Nestlé (SWX:NESN) reported first quarter 2026 group sales of CHF 21,317 million compared with CHF 22,601 million a year earlier, yet the stock reacted positively as investors focused on underlying organic growth and pricing. See our latest analysis for Nestlé. That positive reaction around the sales release sits against a mixed share price picture, with a 7.65% 90 day share price return contrasting with a 6.08% decline in the one year...

UBS Group (SWX:UBSG) is in focus after reporting first quarter 2026 earnings, with net profit of US$3.04b and record revenues across core segments, helped by strong trading and Credit Suisse client integration. See our latest analysis for UBS Group. The strong first quarter results have been followed by a sharp rebound in sentiment, with a 6.02% 7 day share price return and 9.77% 30 day share price return, even though the year to date share price return remains down 9.61%. At the same time,...